Industry News
The pharmaceutical industry, particularly in Indonesia, faces several challenges. The first is that 95% of raw materials for medicines are still imported, placing a financial burden on producers—exacerbated by fluctuations in the Rupiah's exchange rate against foreign currencies.
The variety of diseases continues to grow over time. This presents a challenge for the pharmaceutical industry to keep innovating and creating medicines to alleviate the ailments affecting the public.
The government continues its efforts to provide healthcare services to the Indonesian people through the National Health Insurance - Healthy Indonesia Card (JKN-KIS) program. The government aims to increase JKN participation to 254.6 million people in 2019.
The variety of diseases continues to grow over time. This presents a challenge for the pharmaceutical industry to keep innovating and developing medicines to alleviate the ailments affecting the public.
